Literature DB >> 8895736

The FHIT and PTPRG genes are deleted in benign proliferative breast disease associated with familial breast cancer and cytogenetic rearrangements of chromosome band 3p14.

I Panagopoulos1, N Pandis, S Thelin, C Petersson, F Mertens, A Borg, U Kristoffersson, F Mitelman, P Aman.   

Abstract

We have used nested reverse transcription-PCR (RT-PCR) and PCR on genomic DNA to search for aberrations in the FHIT and PTPRG genes, both located in chromosomal band 3p14.2, in specimens from cytogenetically analyzed benign breast lesions (three samples with atypical hyperplasia and one with fibroadenosis) from two women belonging to breast cancer families. The transcription analysis showed that the FHIT gene was either not expressed or that its expression was dramatically reduced to a level not detectable by nested RT-PCR in the samples with atypical hyperplasia. Genomic analysis of exons 3 and 5 of FHIT and exon 12 of PTPRG provided evidence that these DNA segments were homozygously deleted in the majority of the cells. These data are in line with the histopathological features and cytogenetic findings in the three samples; none contained normal parenchyma, and all had chromosomal aberrations involving band 3p14. RT-PCR analysis of the fibroadenosis specimen, which had a normal karyotype, detected the expected 856-bp fragment as well as an additional alternative transcript variant of FHIT with 1014 bp. The additional 158-bp sequence, which may add 38 amino acids to the NH2-terminal part of the previously described FHIT protein, was inserted between exons 4 and 5 and seems to be a new exon located in intron 4 of FHIT.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8895736

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  12 in total

Review 1.  Role of protein tyrosine phosphatases in cancer.

Authors:  Tasneem Motiwala; Samson T Jacob
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2006

Review 2.  Epigenetic regulation of protein tyrosine phosphatases: potential molecular targets for cancer therapy.

Authors:  Samson T Jacob; Tasneem Motiwala
Journal:  Cancer Gene Ther       Date:  2005-08       Impact factor: 5.987

3.  Crystal structures of HINT demonstrate that histidine triad proteins are GalT-related nucleotide-binding proteins.

Authors:  C Brenner; P Garrison; J Gilmour; D Peisach; D Ringe; G A Petsko; J M Lowenstein
Journal:  Nat Struct Biol       Date:  1997-03

4.  Effect of regulated expression of the fragile histidine triad gene on cell cycle and proliferation.

Authors:  Z Guo; J K Vishwanatha
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

5.  Purification and crystallization of complexes modeling the active state of the fragile histidine triad protein.

Authors:  C Brenner; H C Pace; P N Garrison; A K Robinson; A Rosler; X H Liu; G M Blackburn; C M Croce; K Huebner; L D Barnes
Journal:  Protein Eng       Date:  1997-12

6.  Identification of PTPN23 as a novel regulator of cell invasion in mammary epithelial cells from a loss-of-function screen of the 'PTP-ome'.

Authors:  Guang Lin; Victoria Aranda; Senthil K Muthuswamy; Nicholas K Tonks
Journal:  Genes Dev       Date:  2011-07-01       Impact factor: 11.361

Review 7.  Fragile histidine triad protein: structure, function, and its association with tumorogenesis.

Authors:  Md Imtaiyaz Hassan; Abdullah Naiyer; Faizan Ahmad
Journal:  J Cancer Res Clin Oncol       Date:  2009-12-24       Impact factor: 4.553

8.  Identification of protein tyrosine phosphatase receptor gamma extracellular domain (sPTPRG) as a natural soluble protein in plasma.

Authors:  Elisabetta Moratti; Marzia Vezzalini; Luisa Tomasello; Davide Giavarina; Claudio Sorio
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

Review 9.  Ion Channels, Transporters, and Sensors Interact with the Acidic Tumor Microenvironment to Modify Cancer Progression.

Authors:  Ebbe Boedtkjer
Journal:  Rev Physiol Biochem Pharmacol       Date:  2022       Impact factor: 5.545

10.  Aberrant transcripts of the FHIT gene are expressed in normal and leukaemic haemopoietic cells.

Authors:  M Carapeti; R C Aguiar; H Sill; J M Goldman; N C Cross
Journal:  Br J Cancer       Date:  1998-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.